SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,292,000 | +1232.0% | 11,294 | +884.7% | 0.01% | +800.0% |
| Q3 2019 | $97,000 | +24.4% | 1,147 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $78,000 | -25.7% | 1,129 | -21.8% | 0.00% | 0.0% |
| Q1 2019 | $105,000 | +36.4% | 1,444 | +7.0% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | -11.5% | 1,349 | +20.8% | 0.00% | 0.0% |
| Q3 2018 | $87,000 | +569.2% | 1,117 | +464.1% | 0.00% | – |
| Q2 2018 | $13,000 | +44.4% | 198 | +11.2% | 0.00% | – |
| Q1 2018 | $9,000 | -65.4% | 178 | -64.0% | 0.00% | – |
| Q4 2017 | $26,000 | -62.3% | 495 | -60.7% | 0.00% | -100.0% |
| Q3 2017 | $69,000 | +109.1% | 1,261 | +95.8% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | -17.5% | 644 | +3.0% | 0.00% | 0.0% |
| Q1 2017 | $40,000 | +110.5% | 625 | +74.6% | 0.00% | – |
| Q4 2016 | $19,000 | +11.8% | 358 | +11.5% | 0.00% | – |
| Q3 2016 | $17,000 | +6.2% | 321 | -22.1% | 0.00% | – |
| Q2 2016 | $16,000 | – | 412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |